IDH1 and glioma: Finally, we analyzed the relationship between ABCC3 expressions and clinic characteristics of glioma patients, finding that differentially expressing ABCC3 was remarkably related to age (Figure 5(a)), 1p19q codeletion (Figure 5(b)), PRS type (Figure 5(c)), chemo status (Figure 5(d)), grade (Figure 5(e)), IDH mutation status (Figure 5(f)), and histology (Figure 5(g)).